openPR Logo
Press release

Rise in Prevalence of Influenza Infections Drives the Influenza Medication Market

08-03-2017 03:02 PM CET | Health & Medicine

Press release from: Transparency Market Research

Rise in Prevalence of Influenza Infections Drives the Influenza

Influenza, commonly known as “flu,” is a respiratory disorder caused by an influenza virus. It is an infectious disorder which is of three types: type A, type B, and type C. The common symptoms of the disorder are cough, cold, fever, and sore throat, which can be mild or severe. The disease is spread easily from person to person by sneezing, coughing, or touching surfaces, and is generally diagnosed on the basis of symptoms. Seasonal outbreak of influenza primarily occurs in winter.

Most people generally recover fully, but severe complications such as pneumonia can also develop. The treatment for influenza aims to prevent such complications and to ease the symptoms until the infection is cured. Initiation of antiviral treatment is recommended for hospitalized patients as early as possible. Annual vaccination for influenza is the best way to prevent its infection, as vaccination can be done well before the exposure to the influenza virus, and can provide immunity throughout the season of influenza. The complications of influenza result in more than 200,000 patients in the U.S. to be hospitalized every year.

Browse Market Research Report @ http://www.transparencymarketresearch.com/influenza-medication-market.html

Rise in prevalence of influenza infections and government participation in prevention and treatment of infectious diseases in developing countries are major factors driving the growth of the influenza medication market. However, high cost of antiviral medications is expected to restrain the global market during the forecast period.

The global influenza medication market can be segmented on the basis of therapeutics, distribution channel, and region. Based on the therapeutics, the global influenza medication market is segmented into typical influenza medications (antivirals), light influenza medications (antibiotics), and pneumonia influenza medications. The typical influenza medications segment accounted for a high market share of influenza medications in 2016, which is attributed to its effectiveness.

Antivirals include major three FDA approved drugs, which are zanamivir, oseltamivir, and peramivir. According to CDC, antiviral medications are approximately 70% to 90% effective in the prevention of influenza and are considered to be useful adjuncts to influenza vaccination. Rise in prevalence of influenza in developing countries and shift of population toward preventive health care are expected to drive the market growth of the typical influenza medications segment during the forecast period. However, the light influenza medications segment is anticipated to expand at a significant CAGR during the forecast period due to the rising tendency of population for self-medication in developing countries.

Based on distribution channel, the global market is divided into hospitals, clinics, pharmacies, and others. The hospitals segment dominated the influenza medication market in 2016 due to positive reimbursement policies for manufacturers and rise in incidence of hospitalization for pneumonia type of influenza infections. However, the pharmacies segment is anticipated to lead the market in terms of revenue during the forecast period, owing to the FDA approval of OTC products and rise in per capita income of the population.

For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=24038

Geographically, the global influenza medication market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a large market share in terms of revenue in 2016 owing to the establishment of R&D units by key players in developed countries. Rise in prevalence of influenza infections such as H1N1 and government participation in prevention and control of such infectious diseases are anticipated to boost the North America market during the forecast period. However, Asia Pacific is expected to witness a high growth rate during the forecast period, which is attributed to the rising concern about the prevention of infectious diseases in highly populated countries such as India and China.

Major players operating in the global influenza medication market include Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Bayer AG, Sanofi, Celgene Corporation, and others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rise in Prevalence of Influenza Infections Drives the Influenza Medication Market here

News-ID: 654962 • Views:

More Releases from Transparency Market Research

Photochromic Lenses Market Size & Share to Surpass USD 10.9 Bn by 2031, Exhibiting a CAGR of 5.5% | States Transparency Market Research, Inc
Photochromic Lenses Market Size & Share to Surpass USD 10.9 Bn by 2031, Exhibiti …
Photochromic lenses, known for their ability to adjust to varying light conditions, are gaining significant traction in the eyewear industry. These adaptive lenses darken on exposure to sunlight and clear up indoors, providing convenience and protection. Available in various materials and incorporating advanced technologies, photochromic lenses cater to diverse consumer needs, enhancing their appeal and functionality. In 2022, the global photochromic lenses market was valued at an impressive US$ 6.8 billion.
Hysteroscopes Market Projected to Reach USD 446.6 Mn by 2031, Growing at a CAGR of 5.8%- Transparency Market Research, Inc.
Hysteroscopes Market Projected to Reach USD 446.6 Mn by 2031, Growing at a CAGR …
The hysteroscopes market is poised for significant growth over the next decade, driven by advancements in medical technology and increasing demand for minimally invasive procedures. These specialized medical devices are crucial in the examination and treatment of the uterine cavity, providing both diagnostic and therapeutic benefits. As healthcare technology evolves, hysteroscopes are becoming more sophisticated, offering enhanced precision and patient comfort. This article delves into the projected growth, key drivers,
Respiratory Devices Market Size/Share Worth USD 37.7 Bn by 2031, at a CAGR of 6.1% | Exclusive Report by Transparency Market Research, Inc.
Respiratory Devices Market Size/Share Worth USD 37.7 Bn by 2031, at a CAGR of 6. …
The global respiratory devices market is on the brink of substantial growth, driven by a convergence of technological advancements, an increasing prevalence of respiratory diseases, and demographic shifts such as an aging population. From therapeutic devices like ventilators and inhalers to diagnostic and monitoring tools such as spirometers and pulse oximeters, the respiratory devices market is poised to see a significant upsurge in demand over the coming decade. This detailed
Sharps Containers Market Worth USD 1.0 Bn, at a 4.7% CAGR By 2031 - Transparency Market Research, Inc.
Sharps Containers Market Worth USD 1.0 Bn, at a 4.7% CAGR By 2031 - Transparency …
In the realm of healthcare, the safe disposal of sharps-needles, syringes, and other sharp medical instruments-is not just a regulatory requirement but a crucial element of infection control and workplace safety. The global sharps containers market, valued at US$ 701.1 million in 2022, is set to expand significantly, projected to reach US$ 1.0 billion by 2031 with a steady compound annual growth rate (CAGR) of 4.7%. This growth trajectory underscores

All 5 Releases


More Releases for Influenza

H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,
Influenza Vaccine Market | DPIResearch.com
According to the DPI Research new growth forecast report titled “Worldwide Influenza Vaccines Market Size | Forecast to 2027” to Witness Comprehensive Growth by 2027 DPI Research published a new report on Worldwide Influenza Vaccines Market. The research offers an extensive analysis of key players active in the Worldwide Influenza Vaccines Market. Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research.
Influenza Vaccines
Influenza Drugs and Vaccines Market describes its growth, size, share, Forecast and trends to 2025 Influenza Drugs and Vaccines Market Production and Demand Analysis 2019 to 2025 Influenza Drugs and Vaccines Market 2019 Manufacturing Analysis and Development Forecast 2025 Influenza Drugs and Vaccines Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Influenza Drugs and Vaccines Market to Insight By 2025: Top Key Vendors Influenza Drugs and Vaccines Market Insights 2019, Global and
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In European Ma …
Europe Influenza Market Influenza is an upper respiratory tract disease and is caused by the influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children less than five years of age. The infection may be confirmed by testing
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In U.S. Market
Influenza is an upper respiratory tract disease and is caused by the Influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children with less than 5 years of age. The infection may be confirmed by testing the
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about